“…Previous studies demonstrate that unlike Aroclor 1254, a complete displacement of [ 3 H]TCDD from the Ah receptor was not observed in 2,2',4,4',5,5'-hexaCB competitive binding assays; moreover, [ l25 I 2 ]2,2',5,5'-tetrachloro-4,4'-diiodobiphenyl did not bind directly to the Ah receptor (Davis and Safe, 1990). These results suggest that the antagonism observed for 2,2',4,4',5,5'-hexaCB may occur by mechanisms other than through the Ah receptor (Davis and Safe, 1990). A recent study by De Jongh et al (1995) has shown that the concentration of TCDD in the liver (% dose/ g tissue) was increased in the animals cotreated with TCDD and 2,2',4,4',5,5'-hexaCB compared to the animals treated with TCDD alone.…”